Gladstone Institutes
| Established | 1979 |
|---|---|
| President | R. Sanders Williams |
| Faculty | 30 |
| Staff | 450 |
| Budget | $80 million |
| Location | 1650 Owens St., San Francisco, CA, San Francisco, California, United States |
| Website | http://gladstoneinstitutes.org/ |
Gladstone Institutes is an independent and nonprofit biomedical research organization whose focus is to better understand, prevent, treat and cure cardiovascular, viral and neurological conditions such as heart failure, HIV/AIDS and Alzheimer's disease. Gladstone researchers study these diseases using techniques of basic and translational science. Another focus at Gladstone is building on the breakthrough development of induced pluripotent stem cell technology by one of its investigators, 2012 Nobel Laureate Shinya Yamanaka, to improve drug discovery, personalized medicine and tissue regeneration.
Founded in 1979, Gladstone is affiliated with the University of California, San Francisco (UCSF) and is located in San Francisco, adjacent to UCSF’s Mission Bay campus. Approximately 450 staff members—including more than 300 scientists—work at Gladstone.
Gladstone Institutes was founded in 1979 as a research and training facility housed at San Francisco General Hospital. Under the leadership of Robert Mahley—a leading cardiovascular scientist recruited from the National Institutes of Health—the J. David Gladstone Institutes was launched with a trust valued at $8 million from the late commercial real estate developer, J. David Gladstone.
In 1991 Gladstone expanded its focus to include virology and immunology in response to the growing HIV/AIDS crisis.
In 1998 Gladstone founded a third institute dedicated to studying neurological diseases.
In 2004 the Gladstone Institutes moved to the new facility that it built on San Francisco’s Mission Bay campus. Two years later Gladstone founded a center dedicated to translating its biological discoveries into therapies. Three years later and together with Taube Philanthropies and the Koret Foundation, Gladstone founded the Taube-Koret Center for Huntington's Disease Research, as a direct outgrowth of the growing focus on translational science to study and find treatments for disease.
...
Wikipedia